Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCAHCardinal Health
FinDog View：Bullish
GILDGilead Sciences
FinDog View：Neutral
| Metric | CAH | GILD |
|---|
| Close | 250.48 | 170.68 |
| Market Cap | $58.8B | $213B |
| 1M | +12.58% | +14.51% |
| P/E (TTM) | 34.2 | — |
| Forward P/E | 17.3 | 22.0 |
| P/E 5-Yr Percentile | 38 | — |
| P/S | 0.2 | 7.0 |
| P/B | 58.8 | 17.9 |
| Dividend Yield | 1.88% | 3.98% |
| Latest Quarter Revenue | $64.5B | $8.3B |
| Revenue YoY | +7.1% | +6.8% |
| Gross Margin | 4.4% | 81.1% |
| Latest Quarter EPS | — | 1.94 |
| Avg Post-Earnings Move | ±1.4% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.92% | 2.57% |
| 90-Day Net Insider Buying | −$59.6M | −$15.9M |
CAH · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
